Boston Scientific Corp (NYSE:BSX)
$ 73.69 -0.41 (-0.55%) Market Cap: 108.34 Bil Enterprise Value: 117.01 Bil PE Ratio: 61.92 PB Ratio: 5.44 GF Score: 85/100

Boston Scientific Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 12, 2020 / 01:00PM GMT
Release Date Price: $36.74 (-1.76%)
Vikramjeet Singh Chopra;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Okay. Good morning, everyone. My name is Vik Chopra. I work on the medical supplies and devices team at Credit Suisse. Very happy to host Boston Scientific this morning. We have Meghan Scanlon, SVP and President of Urology and Pelvic Health as well as Susie Lisa and Lauren Tengler from the Investor Relations department.

So Meghan, thank you once again for making the time. We really appreciate your participation this morning. And I think we can just start it off with some Q&A perhaps.

Meghan Scanlon
Boston Scientific Corporation - Senior VP and President of Urology & Pelvic Health

Absolutely. Thanks for having me, Vik.

Questions & Answers

Vikramjeet Singh Chopra;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Yes. Of course, of course. And then just kind of looking at overall general trends on -- in the business that you run, the Urology and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot